The Physiology of Cardiovascular Disease and Innovative Liposomal Platforms for Therapy

International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s30599
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Heart Rate: A Global Target for Cardiovascular Disease and Therapy Along the Cardiovascular Disease Continuum

Journal of Cardiology
Cardiovascular MedicineCardiology
2013English

Fixed-Dose Combination Therapy for the Prevention of Cardiovascular Disease

2014English

Applied Cardiovascular Physiology

Anaesthesia and Intensive Care Medicine
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2019English

Clinical Cardiovascular Physiology

BMJ
1976English

The Cardiovascular Physiology and Pharmacology of Endothelin-1

Advances in Pharmacology
2010English

Gene Therapy for Cardiovascular Disease: A Case for Cautious Optimism

Hypertension
Internal Medicine
2001English

Oligonucleotide-Based Gene Therapy for Cardiovascular Disease Are Oligonucleotide Therapeutics Novel Cardiovascular Drugs

Current Drug Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2000English

Androgen Deprivation Therapy and Cardiovascular Disease: What Is the Linking Mechanism?

Therapeutic Advances in Urology
Urology
2015English

The Biopontis Alliance Rare Disease Foundation (BARDF) – An Innovative Model for Early Stage Rare Disease Therapy Financing and Development

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy